Nancy Wysenski
CIK: 0001294596
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CYTOKINETICS INC
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Oct 16, 2026CYTK
CYTOKINETICS INC
Award(A)Direct97 shares at avg. $63.92$6K - Jul 15, 2026CYTK
CYTOKINETICS INC
Award(A)Direct75 shares at avg. $82.62$6K - May 27, 2026CYTK
CYTOKINETICS INC
Award(A)Direct2.9K shares- - Apr 15, 2026CYTK
CYTOKINETICS INC
Award(A)Direct95 shares at avg. $65.37$6K - Jan 15, 2026CYTK
CYTOKINETICS INC
Award(A)Direct98 shares at avg. $63.44$6K - Oct 15, 2025CYTK
CYTOKINETICS INC
Award(A)Direct99 shares at avg. $62.80$6K - Jul 15, 2025CYTK
CYTOKINETICS INC
Award(A)Direct164 shares at avg. $38.01$6K - May 14, 2025CYTK
CYTOKINETICS INC
Award(A)Direct7.3K shares- - Apr 15, 2025CYTK
CYTOKINETICS INC
Award(A)Direct162 shares at avg. $38.56$6K - Jan 2, 2025CYTK
CYTOKINETICS INC
Award(A)Direct127 shares at avg. $48.93$6K - Oct 1, 2024CYTK
CYTOKINETICS INC
Award(A)Direct118 shares at avg. $52.60$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 | CYTK CYTOKINETICS INC | Award(A) | 97 | $63.92 | $6,200 | Direct |
| Jul 15, 2026 | CYTK CYTOKINETICS INC | Award(A) | 75 | $82.62 | $6,197 | Direct |
| May 27, 2026 | CYTK CYTOKINETICS INC | Award(A) | 2,851 | - | $0 | Direct |
| Apr 15, 2026 | CYTK CYTOKINETICS INC | Award(A) | 95 | $65.37 | $6,210 | Direct |
| Jan 15, 2026 | CYTK CYTOKINETICS INC | Award(A) | 98 | $63.44 | $6,217 | Direct |
| Oct 15, 2025 | CYTK CYTOKINETICS INC | Award(A) | 99 | $62.80 | $6,217 | Direct |
| Jul 15, 2025 | CYTK CYTOKINETICS INC | Award(A) | 164 | $38.01 | $6,234 | Direct |
| May 14, 2025 | CYTK CYTOKINETICS INC | Award(A) | 7,333 | - | - | Direct |
| Apr 15, 2025 | CYTK CYTOKINETICS INC | Award(A) | 162 | $38.56 | $6,247 | Direct |
| Jan 2, 2025 | CYTK CYTOKINETICS INC | Award(A) | 127 | $48.93 | $6,214 | Direct |
| Oct 1, 2024 | CYTK CYTOKINETICS INC | Award(A) | 118 | $52.60 | $6,207 | Direct |
1-11 of 11 transactions
About Wysenski Nancy
Wysenski Nancy (SEC CIK 0001294596) files insider reports with the SEC as Director of CYTOKINETICS INC (CYTK).
Signal8 holds 11 ownership filings by Wysenski Nancy, all Form 4s, filed between Oct 3, 2024 and Oct 20, 2026. Those filings report 11 transactions, from Oct 1, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wysenski Nancy's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Wysenski Nancy
- Oct 16, 2026: Grant or award of CYTK shares (Form 4, code A).
- Jul 15, 2026: Grant or award of CYTK shares (Form 4, code A).
- May 27, 2026: Grant or award of CYTK shares (Form 4, code A).
- Apr 15, 2026: Grant or award of CYTK shares (Form 4, code A).
- Jan 15, 2026: Grant or award of CYTK shares (Form 4, code A).
Other insiders filing for CYTOKINETICS INC (CYTK)
- Malik Fady Ibraham, EVP Research & Development
- Blum Robert I, President & CEO
- Kaye Edward M. MD, Director
- Harrington Robert Arthur, Director
- Daly James M, Director
- WIERENGA WENDELL, Director